Who is sponsoring NCT04214054?

NCT04214054 is sponsored by Nourhan M.Aly.

What condition does NCT04214054 study?

NCT04214054 studies Maxillary Sinus Augmentation.

Is NCT04214054 still recruiting?

NCT04214054 is currently completed. Last updated 20 August 2020.

Last reviewed 2020-08-20 · How we verify

NCT04214054

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Maxillary Sinus Lift With and Without Self-hardening Biphasic Calcium Phosphate.

Completed NA Last updated 20 August 2020

What this trial tests

NA trial testing Moldable self-hardening biphasic calcium phosphate graft in Maxillary Sinus Augmentation in 20 participants. Completed in 25 September 2019.

Timeline

13 May 2018

Primary endpoint
20 April 2019

25 September 2019

Quick facts

Lead sponsor	Nourhan M.Aly
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	13 May 2018
Primary completion	20 April 2019
Estimated completion	25 September 2019
Sites	1 location across Egypt

Drugs / interventions tested

Moldable self-hardening biphasic calcium phosphate graft
No graft material placed - Blood Clot only

Conditions studied

Maxillary Sinus Augmentation — all drugs for Maxillary Sinus Augmentation →

Sponsor

Nourhan M.Aly — full company profile →

Who can join

Adults 30 to 50, any sex, with Maxillary Sinus Augmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was carried out to compare the outcome of sinus lift without grafting material, versus the use of moldable, self hardening calcium phosphate biomaterials with simultaneous implant placement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Nourhan M.Aly trials

Trials by the same sponsor.

NCT06763419 — Internal Photobiomodulation For Management Of Temporomandibular Joint Internal Derangement · NA · recruiting
NCT06146296 — THE EFFECT OF VITAMIN C ON POST-ORTHODONTIC TREATMENT RELAPSE · Phase 2, PHASE3 · unknown
NCT05811728 — Three-dimensional Assessment of the Bone Changes Accompanying Laser-assisted Orthodontic Tooth Movement · NA · completed
NCT06352658 — Efficacy of Different Treatments for Obstructive Sleep Apnea · NA · completed
NCT05782088 — Single Versus Repeated Piezocision-assisted Orthodontic Tooth Movement · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04214054 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nourhan M.Aly
Last refreshed: 20 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04214054.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing